Viewing Study NCT07221227


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:10 AM
Study NCT ID: NCT07221227
Status: RECRUITING
Last Update Posted: 2025-10-31
First Post: 2025-10-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module